ResearchSafe

Progesterone (Micronized Progesterone (Prometrium))

Category: Hormone Replacement. Status: FDA Approved.

A bioidentical hormone with neuroprotective, sleep-promoting, and anti-estrogenic properties. Used in both male and female HRT protocols for mood stabilization, deep sleep enhancement, and estrogen balancing.

How it works

Agonizes progesterone receptors and GABA-A receptors (via allopregnanolone metabolite). Inhibits 5-alpha reductase, opposes estrogen proliferative effects, and promotes myelination in neural tissue.

Key facts

  • Molecular weight: 314.46 Da
  • Half-life: ~16-18 hours (oral micronized)
  • Bioavailability: ~10% oral (first-pass); ~100% topical/vaginal
  • Storage: Room temperature. Protect from light and moisture.

Dosing overview

  • Typical dose: 100-200 mg oral or 20-40 mg topical
  • Frequency: Nightly (oral) or daily (topical)
  • Duration: Ongoing
  • Route: Oral capsule, topical cream, or vaginal

Reported benefits

  • Enhanced deep sleep (GABA modulation)
  • Neuroprotection
  • Estrogen opposition
  • Reduced anxiety
  • DHT reduction (5AR inhibition)
  • Cardiovascular protection

Possible side effects

  • Drowsiness
  • Mild dizziness
  • Breast tenderness
  • Mood changes (rare)
  • Bloating

Research

  • Progesterone and neuroprotection after TBI (2020): Progesterone reduced neuronal cell death by 40% and improved cognitive outcomes in traumatic brain injury models.
  • Oral progesterone and sleep architecture (2019): Micronized progesterone increased slow-wave sleep by 25% without next-day sedation, via allopregnanolone GABA modulation.

Compare Progesterone

Community discussions about Progesterone

Research and educational reference only. Not medical advice.